MAKING SCIENCE GROUP SA (ALMKS.PA) Stock Fundamental Analysis
EPA:ALMKS - Euronext Paris - Matif - ES0105463006 - Common Stock - Currency: EUR
Taking everything into account, ALMKS scores 3 out of 10 in our fundamental rating. ALMKS was compared to 69 industry peers in the Media industry. ALMKS may be in some trouble as it scores bad on both profitability and health. ALMKS is growing strongly while it is still valued neutral. This is a good combination!
1. Profitability
1.1 Basic Checks
ALMKS had positive earnings in the past year.
In the past year ALMKS had a positive cash flow from operations.
In multiple years ALMKS reported negative net income over the last 5 years.
In multiple years ALMKS reported negative operating cash flow during the last 5 years.
1.2 Ratios
ALMKS's Return On Assets of 0.39% is on the low side compared to the rest of the industry. ALMKS is outperformed by 69.35% of its industry peers.
Looking at the Return On Equity, with a value of 3.25%, ALMKS is in line with its industry, outperforming 41.94% of the companies in the same industry.
ALMKS has a Return On Invested Capital of 9.78%. This is in the better half of the industry: ALMKS outperforms 77.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.39% | ||
| ROE | 3.25% | ||
| ROIC | 9.78% |
ROA(3y)-3.19%
ROA(5y)-0.63%
ROE(3y)-30.41%
ROE(5y)27.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ALMKS has a Profit Margin of 0.25%. This is in the lower half of the industry: ALMKS underperforms 70.97% of its industry peers.
With a Operating Margin value of 3.03%, ALMKS is not doing good in the industry: 67.74% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of ALMKS has declined.
Looking at the Gross Margin, with a value of 22.07%, ALMKS is doing worse than 87.10% of the companies in the same industry.
In the last couple of years the Gross Margin of ALMKS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.03% | ||
| PM (TTM) | 0.25% | ||
| GM | 22.07% |
OM growth 3Y-49.74%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.87%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALMKS is creating some value.
The number of shares outstanding for ALMKS has been increased compared to 1 year ago.
The debt/assets ratio for ALMKS is higher compared to a year ago.
2.2 Solvency
ALMKS has an Altman-Z score of 1.69. This is a bad value and indicates that ALMKS is not financially healthy and even has some risk of bankruptcy.
ALMKS has a Altman-Z score (1.69) which is in line with its industry peers.
The Debt to FCF ratio of ALMKS is 4.69, which is a neutral value as it means it would take ALMKS, 4.69 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 4.69, ALMKS perfoms like the industry average, outperforming 54.84% of the companies in the same industry.
ALMKS has a Debt/Equity ratio of 1.50. This is a high value indicating a heavy dependency on external financing.
ALMKS has a Debt to Equity ratio of 1.50. This is in the lower half of the industry: ALMKS underperforms 74.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.5 | ||
| Debt/FCF | 4.69 | ||
| Altman-Z | 1.69 |
ROIC/WACC1.41
WACC6.96%
2.3 Liquidity
A Current Ratio of 0.74 indicates that ALMKS may have some problems paying its short term obligations.
ALMKS has a Current ratio of 0.74. This is in the lower half of the industry: ALMKS underperforms 72.58% of its industry peers.
ALMKS has a Quick Ratio of 0.74. This is a bad value and indicates that ALMKS is not financially healthy enough and could expect problems in meeting its short term obligations.
ALMKS has a worse Quick ratio (0.71) than 70.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.74 | ||
| Quick Ratio | 0.71 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 106.31% over the past year.
ALMKS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.46%.
Measured over the past years, ALMKS shows a very strong growth in Revenue. The Revenue has been growing by 59.87% on average per year.
EPS 1Y (TTM)106.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.36%
Revenue 1Y (TTM)9.46%
Revenue growth 3Y59.87%
Revenue growth 5YN/A
Sales Q2Q%10.63%
3.2 Future
ALMKS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 130.35% yearly.
The Revenue is expected to grow by 10.42% on average over the next years. This is quite good.
EPS Next Y555.56%
EPS Next 2Y210.91%
EPS Next 3Y130.35%
EPS Next 5YN/A
Revenue Next Year14.49%
Revenue Next 2Y11.37%
Revenue Next 3Y10.42%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 132.50, which means the current valuation is very expensive for ALMKS.
ALMKS's Price/Earnings ratio is a bit more expensive when compared to the industry. ALMKS is more expensive than 75.81% of the companies in the same industry.
ALMKS is valuated expensively when we compare the Price/Earnings ratio to 28.47, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 8.96, the valuation of ALMKS can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALMKS indicates a somewhat cheap valuation: ALMKS is cheaper than 66.13% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ALMKS to the average of the S&P500 Index (92.74), we can say ALMKS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 132.5 | ||
| Fwd PE | 8.96 |
4.2 Price Multiples
ALMKS's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ALMKS is more expensive than 61.29% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ALMKS is valued a bit cheaper than the industry average as 77.42% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.23 | ||
| EV/EBITDA | 9.52 |
4.3 Compensation for Growth
ALMKS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALMKS's earnings are expected to grow with 130.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.24
PEG (5Y)N/A
EPS Next 2Y210.91%
EPS Next 3Y130.35%
5. Dividend
5.1 Amount
No dividends for ALMKS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
MAKING SCIENCE GROUP SA
EPA:ALMKS (2/4/2025, 7:00:00 PM)
7.95
-0.05 (-0.62%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)
Earnings (Next)
Inst Owners2.65%
Inst Owner ChangeN/A
Ins Owners69.38%
Ins Owner ChangeN/A
Market Cap71.39M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 132.5 | ||
| Fwd PE | 8.96 | ||
| P/S | 0.29 | ||
| P/FCF | 5.23 | ||
| P/OCF | 4.96 | ||
| P/B | 3.76 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.52 |
EPS(TTM)0.06
EY0.75%
EPS(NY)0.89
Fwd EY11.16%
FCF(TTM)1.52
FCFY19.12%
OCF(TTM)1.6
OCFY20.15%
SpS27.6
BVpS2.12
TBVpS-5.13
PEG (NY)0.24
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.39% | ||
| ROE | 3.25% | ||
| ROCE | 14.11% | ||
| ROIC | 9.78% | ||
| ROICexc | 17.03% | ||
| ROICexgc | N/A | ||
| OM | 3.03% | ||
| PM (TTM) | 0.25% | ||
| GM | 22.07% | ||
| FCFM | 5.51% |
ROA(3y)-3.19%
ROA(5y)-0.63%
ROE(3y)-30.41%
ROE(5y)27.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-49.74%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.87%
GM growth 5YN/A
F-Score5
Asset Turnover1.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.5 | ||
| Debt/FCF | 4.69 | ||
| Debt/EBITDA | 2.56 | ||
| Cap/Depr | 20.14% | ||
| Cap/Sales | 0.3% | ||
| Interest Coverage | 1.39 | ||
| Cash Conversion | 128.77% | ||
| Profit Quality | 2212.76% | ||
| Current Ratio | 0.74 | ||
| Quick Ratio | 0.71 | ||
| Altman-Z | 1.69 |
F-Score5
WACC6.96%
ROIC/WACC1.41
Cap/Depr(3y)269.23%
Cap/Depr(5y)362.44%
Cap/Sales(3y)9.24%
Cap/Sales(5y)8.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)106.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.36%
EPS Next Y555.56%
EPS Next 2Y210.91%
EPS Next 3Y130.35%
EPS Next 5YN/A
Revenue 1Y (TTM)9.46%
Revenue growth 3Y59.87%
Revenue growth 5YN/A
Sales Q2Q%10.63%
Revenue Next Year14.49%
Revenue Next 2Y11.37%
Revenue Next 3Y10.42%
Revenue Next 5YN/A
EBIT growth 1Y383.07%
EBIT growth 3Y-19.64%
EBIT growth 5YN/A
EBIT Next Year554.17%
EBIT Next 3Y107.69%
EBIT Next 5YN/A
FCF growth 1Y261.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y373.2%
OCF growth 3YN/A
OCF growth 5YN/A